Latest

21st Century Cures bill advances to House floor

21st Century Cures bill advances to House floor

The legislation would allow drugmakers to share economic information with payers beyond what is included on the FDA-approved label.

OPDP finds fault with Rapaflo website

The FDA's advertising division said images and copy for the BPH drug Rapaflo are misleading.

UCLA looks to Twitter for health trends

UCLA looks to Twitter for health trends

Researchers say Twitter could provide critical insight into health needs for hard-to-reach groups.

Five things for pharma marketers to know: Thursday, May 21

Five things for pharma marketers to know: Thursday, May 21

CVS will buy institutional pharmacy Omnicare in a $12.7-billion deal; ProPublica says the FDA and GlaxoSmithKline failed to protect patients from misusing Advair; Regeneron and Sanofi expect to file RA drug sarilumab with the FDA in the fourth quarter of this year

Pharma and Self-Perception: Knights, Knaves or Pawns?

Pharma and Self-Perception: Knights, Knaves or Pawns?

Even the industry's sunniest personalities don't deny that pharma has an image problem among outside constituencies, with an unfortunately high percentage of observers believing the biz is first and foremost about profits. Sachin Jain dives deep on this and other perceptions—accurate and otherwise—about the industry and its marketing machinery

Giant names Gold as CEO, adds CFO

Giant names Gold as CEO, adds CFO

The West Coast independent agency redefined its leadership team with the appointments of founding principal Steven Gold as CEO and Jeff Nemy as CFO.

Banner triggers OPDP letter to Oak Pharmaceuticals

The FDA's bad-ad group said the banner they saw at a professional conference was misleading.

Five things for pharma marketers to know: Wednesday, May 20

Five things for pharma marketers to know: Wednesday, May 20

FDA official says DTC risk claims are a waste of time; one analyst believes Afrezza could turn around sluggish sales; J&J inks billion-dollar deal to commercialize HCV drugs

Centron scuttles HealthStar name, sells LehmanMillet

Centron scuttles HealthStar name, sells LehmanMillet

The new Centron includes renamed medical education, public relations and market access divisions.

Torres: Career challenges prepared her to take reins at McNeil

Torres: Career challenges prepared her to take reins at McNeil

McNeil Consumer Healthcare president Denice Torres was named woman of the year by the Healthcare Businesswomen's Association.

Cancer center and tech co. test Apple Watch in breast-cancer patients

Cancer center and tech co. test Apple Watch in breast-cancer patients

Parties in the effort say the novelty of wearing an Apple Watch, along with a newly developed app, may help clinicians refine treatment plans and patient support.

Five things for pharma marketers to know: Tuesday, May 19

Five things for pharma marketers to know: Tuesday, May 19

Perrigo says a Mylan deal is possible; new guidelines may reduce cancer screenings; Takeda petitions dictionaries to add a new definition for depression

Inhaled insulin stymied by drive for value

Inhaled insulin stymied by drive for value

Experts say Afrezza's tepid launch may have more to do with value proposition than product positioning.

Five things for pharma marketers to know: Monday, May 18

Five things for pharma marketers to know: Monday, May 18

Endo agrees to buy Par Pharmaceuticals for $8 billion; AstraZeneca deepens commitment to biologics; FDA cautions that certain diabetes drugs could lead to serious condition

Makovsky's head of health moving to Finn Partners

Makovsky's head of health moving to Finn Partners

Long-time practice lead Gil Bashe is tasked with unifying and building the health function at global firm Finn Partners.

Agency Spotlight


The 2015 healthcare agency questionnaire, for firms hoping to be featured in the Top 100 Agencies issue, is live. Click here to be considered.

Email Newsletters